Cancer stem cells in leukemia, recent advances

Journal of Cellular Physiology

Volumn 213, Issue 2, 2007, Pages 440-444

  Zou, Gang Ming ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCR ABL PROTEIN; HERMES ANTIGEN; MAMMALIAN TARGET OF RAPAMYCIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PU 1;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; BLOOD CELL; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STEM CELL; CARCINOGENESIS; CELL FUNCTION; CELL RENEWAL; CELL TRANSPLANTATION; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DNA REPAIR; HEMATOLOGIC MALIGNANCY; HEMATOPOIESIS; HUMAN; LEUKEMIA; LYMPHATIC SYSTEM; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD44; HEMATOPOIESIS; HUMANS; LEUKEMIA; NEOPLASMS; NEOPLASTIC STEM CELLS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS;

EID: 34648831012     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21140     Document Type: Review

References (52)

1. Adolfsson J, Borge OJ, Bryder D, Theilgaard-Monch K, Astrand-Grundstrom I, Sitnicka E, Sasaki Y, Jacobsen SE. 2001. Upregulation of Flt3 expression within the bone marrow Lin(-) Sca1 (+)c-kit(+) stem cell compartment is accompanied by loss of self-renewal capacity. Immunity 15:659-669.
2. Amaravadi L, Klemsz MJ. 1999. DNA methylation and chromatin structure regulate PU. I expression. DNA Cell Biol 18:875-884.
3. Arai F, Suda T. 2007. Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche. Ann N Y Acad Sci [Epub ahead of print].
4. Bhardwaj G, Murdoch B, Wu D, Baker DP, Williams KP, Chadwick K, Ling LE, Karanu FN, Bhatia M. 2001. Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2:172-180.
5. Bonnet D, Dick JE. 1997. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 3:730-737.
6. Clarke MF. 2005. A self-renewal assay for cancer stem cells. Cancer Chemother Pharmacol 56:64-68. Review.
7. Clarke MF, Fuller M. 2006. Stem cells and cancer: Two faces of eve. Cell 124:1111-1115.
8. Copland M, Fraser AR, Harrison SJ, Holyoake TL. 2005. Targeting the silent minority: Emerging immunotherapeutic strategies for eradication of malignant stem cells in chronic myeloid leukaemia. Cancer Immunol Immunother 54:297-306. Review.
9. Dingli D, Michor F. 2006. Successful therapy must eradicate cancer stem cells. Stem Cells 24:2603-2610.
10. Eisterer W, Jiang X, Christ O, Glimm H, Lee KH, Pang E, Lambie K, Shaw G, Holyoake TL, Petzer AL, Auewarakul C, Barnett MJ, Eaves CJ, Eaves AC. 2005. Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease. Leukemia 19:435-441.
11. Gadhoum Z, Delaunay J, Maquarre E, Durand L, Lancereaux V, Qi J, Robert-Lezenes J, Chomienne C, Smadja-Joffe F. 2004a. The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells. Leuk Lymphoma 45:1501-1510. Review.
12. Gadhoum Z, Leibovitch MP, Qi J, Dumenil D, Durand L, Leibovitch S, Smadja-Joffe F. 2004b. CD44: A new means to inhibit acute myeloid leukemia cell proliferation via p27Kip1. Blood 103:1059-1068.
13. Gering M, Patient R. 2005. Hedgehog signaling is required for adult blood stem cell formation in zebrafish embryos. Dev Cell 8:389-400.
14. Holyoake TL, Jiang X, Drummond MW, Eaves AC, Eaves CJ. 2002. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Leukemia 16:549-558. Review.
15. Houston IB, Huang KJ, Jennings SR, Dekoter RP. 2007. PU.1 immortalizes hematopoietic progenitors in a GM-CSF-dependent manner. Exp Hematol 35:374-384.
16. Jamieson CH, Ailles LE, Dylla SJ, Muijtjens M, Jones C, Zehnder JL, Gotlib J, Li K, Manz MG, Keating A, Sawyers CL, Weissman IL. 2004. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N Engl J Med 351:657-667.
17. Jin L, Hope KJ, Zhai Q, Smadja-Joffe F, Dick JE. 2006. Targeting of CD44 eradicates human acute myeloid leukemic stem cells. Nat Med 12:1167-1174.
18. Jordan CT. 2002. Unique molecular and cellular features of acute myelogenous leukemia stem cells. Leukemia 16:559-562. Review.
19. Jordan CT, Guzman ML, Noble M. 2006. Cancer stem cells. N Engl J Med 355:1253-1261. Review.
20. Jorgensen HG, Allan EK, Mountford JC, Richmond L, Harrison S, Elliott MA, Holyoake TL. 2005. Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylate. Exp Hematol 33:1140-1146.
21. Kato Y, Iwama A, Tadokoro Y, Shimoda K, Minoguchi M, Akira S, Tanaka M, Miyajima A, Kitamura T, Nakauchi H. 2005. Selective activation of STAT5 unveils its role in stem cell self-renewal in normal and leukemic hematopoiesis. J Exp Med 202:169-179.
22. Krause DS, Lazarides K, von Andrian UH, Van Etten RA. 2006. Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med 12:1175-1180.
23. Krivtsov AV, Twomey D, Feng Z, Stubbs MC, Wang Y, Faber J, Levine JE, Wang J, Hahn WC, Gilliland DG, Golub TR, Armstrong SA. 2006. Transformation from committed progenitor to leukaemia stem cell initiated by MLL- AF9. Nature 442:818-822.
24. Lapidot T, Kollet O. 2002. The essential roles of the chemokine SDF-1 and its receptor CXCR4 in human stem cell homing and repopulation of transplanted immune-deficient NOD/SCID and NOD/SCID/B2m(null) mice. Leukemia 16:1992-2003. Review.
25. Levis M, Murphy KM, Pham R, Kim KT, Stine A, Li L, McNiece I, Smith BD, Small D. 2005. Internal tandem duplications of the FLT3 gene are present in leukemia stem cells. Blood 106:673-680.
26. Li L, Neaves WB. 2006. Normal stem cells and cancer stem cells: The niche matters. Cancer Res 66:4553-4557.
27. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, Wicha M, Clarke MF, Simeone DM. 2007. Identification of pancreatic cancer stem cells. Cancer Res 67:1030-1037.
28. Liu J, Jiang G. 2006. CD44 and hematologic malignancies. Cell Mol Immunol 3:359-365. Review.
29. Maehama T, Dixon JE. 1998. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 273:13375-13378.
30. Massard C, Deutsch E, Soria JC. 2006. Tumour stem cell-targeted treatment: Elimination or differentiation. Ann Oncol 17:1620-1624.
31. Meierhoff G, Dehmel U, Gruss HJ, Rosnet O, Birnbaum D, Quentmeier H, Dirks W, Drexler HG. 1995. Expression of FLT3 receptor and FLT3-ligand in human leukemia-lymphoma cell lines. Leukemia 9:1368-1672.
32. Neves H, Weerkamp F, Gomes AC, Naber BA, Gameiro P, Becker JD, Lucio P, Clode N, van Dongen JJ, Staal FJ, Parreira L. 2006. Effects of Delta1 and Jagged1 on early human hematopoiesis: Correlation with expression of notch signaling-related genes in CD34+ cells. Stem Cells 24:1328-1337.
33. O'Brien CA, Pollett A, Gallinger S, Dick JE. 2007. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110.
34. Rizo A, Vellenga E, de Haan G, Schuringa JJ. 2006. Signaling pathways in self-renewing hematopoietic and leukemic stem cells: Do all stem cells need a niche? Hum Mol Genet 2:R210-R219.
35. Rosenbauer F, Koschmjeder S, Steidl U, Tenen DG. 2005. Effect of transcription-factor concentrations on leukemic stem cells. Blood 106:1519-1524.
36. Rowley JD. 1973. Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290-293.
37. Schofield R. 1978. The relationship between the spleen colony-forming cell and the haemopoietic stem cell. Blood Cells 4:7-25.
38. Sitnicka E, Buza-Vidas N, Larsson S, Nygren JM, Liuba K, Jacobsen SE. 2003. Human CD34+ hematopoietic stem cells capable of multilineage engrafting NOD/SCID mice express flt3: Distinct flt3 and c-kit expression and response patterns on mouse and candidate human hematopoietic stem cells. Blood 102:881-886.
39. Smadja-Joffe F, Coulombel L. 2006. Targeting of CD44 to eradicate leukemic stem cells. Med Sci (Paris) 22:1003-1005.
40. Soltysova A, Altanerova V, Altaner C. 2005. Cancer stem cells. Neoplasma 52:435-440.
41. Staal FJ, Clevers HC. 2005. WNT signalling and haematopoiesis: A WNT-WNT situation. Nat Rev Immunol 5:21-30. Review.
42. Steidl U, Rosenbauer F, Verhaak RG, Gu X, Ebralidze A, Otu HH, Klippel S, Steidl C, Bruns I, Costa DB, Wagner K, Aivado M, Kobbe G, Valk PJ, Passegue E, Libermann TA, Delwel R, Tenen DG. 2006. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells. Nat Genet 38:1269-1277.
43. Sugiyama T, Kohara H, Noda M, Nagasawa T. 2006. Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity 25:977-988.
44. Suzuki T, Chiba S. 2005. Notch signaling in hematopoietic stem cells. Int J Hematol 82:285-294. Review.
45. Till JE, McCulloch EA. 1961. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res 14:213-222.
46. Trowbridge JJ, Scott MP, Bhatia M. 2006. Hedgehog modulates cell cycle regulators in stem cells to control hematopoietic regeneration. Proc Natl Acad Sci USA 103:14134-14139.
47. Williams DA, Cancelas JA. 2006. Leukaemia: Niche retreats for stem cells. Nature 444:827-828.
48. Xie T, Spradling AC. 2000. A niche maintaining germ line stem cells in the Drosophila ovary. Science 290:328-330.
49. Yilmai OH, Valdez R, Theisen BK, Guo W, Ferguson DO, Wu H, Morrison SJ. 2006. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441:475-482.
50. Zou GM. 2007. Protein tyrosine phosphatase Shp-2 in Cytokine signalings and stem cell regulations. In: Fong CA, editor. Stem cell research developments. Hauppauge, NY: Nova Science Publishers, Inc. (In press).
51. Zou GM, Wu W, Chen J, Rowley JD. 2003. Duplexes of 21-nucleotide RNAs mediate RNA interference in differentiated mouse ES cells. Biol Cell 95:365-371.
52. Zou GM, Chen JJ, Yoder MC, Wu W, Rowley JD. 2005. Knockdown of Pu.1 by small interfering RNA in CD34+ embryoid body cells derived from mouse ES cells turns cell fate determination to pro-B cells. Proc Natl Acad Sci USA 102:13236-13241.